Differential mechanisms of resistance to sublethal systemic Aspergillus fumigatus infection in immunocompetent BALB/c and C57BL/6 mice

Immunobiology

Volumn 216, Issue 1-2, 2011, Pages 234-242

  Mirkov, Ivana ^a   Stojanovic, Ivana ^a   Glamoclija, Jasmina ^a   Stosic Grujicic, Stanislava ^a   Zolotarevski, Lidija ^b   Kataranovski, Dragan ^a   Kataranovski, Milena ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Aspergillus fumigatus; BALB c and C57BL 6 mice; IFN ; IL 4 and IL 17; S systemic infection; Spleen

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLOSIS; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONIDIUM; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FUNGUS IMMUNITY; HEMATOPOIESIS; IMMUNOCOMPETENCE; INFECTION RESISTANCE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN WEIGHT; STRAIN DIFFERENCE; SURVIVAL RATE;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL COUNT; CELLS, CULTURED; CYTOKINES; DISEASE SUSCEPTIBILITY; IMMUNITY, ACTIVE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TH1 CELLS; TH1-TH2 BALANCE; TH2 CELLS;

EID: 78649498787     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.04.007     Document Type: Article

References (48)

1. Abbas A.K., Lichtman A.H., Pillai S. Cytokines. Cellular and Molecular Immunology 2007, 267-303. Saunders Elsevier, Philadelphia. 6th edn. W. Schmitt, R. Gruliow (Eds.).
2. Armstrong-James D.P.H., Turnbull S.A., Teo I., Stark J., Rogers N.J., Rogers T.R.F., Bignell E., Haynes K. Impaired interferon-γ responses, increased interleukin-17 expression, and tumor necrosis factor-α transcriptional program in invasive aspergillosis. J. Infect. Dis. 2009, 200:1341-1351.
3. Bernhisel-Broadbent J., Camargo E.E., Jaffe H.S., Lederman H.M. Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease. J. Infect. Dis. 1991, 163:908-911.
4. Bi Y., Liu G., Yang R. Th17 cell induction and immune regulatory effects. J. Cell. Physiol. 2007, 211:273-278.
5. Booth C. Fungal culture media. Methods in Microbiology 1971, 49-94. Academic Press, London/New York. 4th edn. J.R. Norris, D.W. Ribbons (Eds.).
6. Corbel M.J., Eades S.M. Examination of the effect of age and acquired immunity on the susceptibility of mice to infection with Aspergillus fumigatus. Mycopathologia 1977, 60:79-85.
7. Cenci E., Perito S., Enssle K.H., Mosci P., Latge J.P., Romani L., Bistoni F. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect. Immun. 1997, 65:564-570.
8. Cenci E., Mencacci A., d'Ostiani C.F., Del Sero G., Mosci P., Montagnoli C., Bacci A., Del Sero G., Perito S., Bistoni F., Romani L. Cytokine- and T helper-dependent immunity in murine aspergillosis. Res. Immunol. 1998, 149:445-454.
9. Cenci E., Mencacci A., Del Sero G., Bacci A., Montagnoli C., d'Ostiani C.F., Mosci P., Bachmann M., Bistoni F., Kopf M., Romani L. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J. Infect. Dis. 1999, 180:1957-1968.
10. Centeno-Lima S., Silveira H., Casimiro C., Aguiar P., do Rosario V.E. Kinetics of cytokine expression in mice with invasive aspergillosis: lethal infection and protection. FEMS Immunol. Med. Microbiol. 2002, 32:167-173.
11. Clemons K.V., Grunig G., Sobel R.A., Mirels L.F., Rennick D.M., Stevens D.A. Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin. Exp. Immunol. 2000, 122:186-191.
12. Clemons K.V., Stevens D.A. The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med. Mycol. 2005, 43:S101-S110.
13. Curtis M.M., Way S.S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 2009, 126:177-185.
14. De Repentigny L., Petitbois S., Boushira M., Michaliszyn E., Senechal S., Gendron N., Montplaisir S. Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect. Immun. 1993, 61:3791-3802.
15. Gervais F., Stevenson M., Skamene E. Genetic control of resistance to Listeria monocytogenes: regulation of leukocyte inflammatory responses by the Hc locus. J. Immunol. 1984, 132:2078-2083.
16. Goodley J.M., Clayton Y.M., Hay R.J. Environmental sampling for aspergilli during building construction on a hospital site. J. Hosp. Infect. 1994, 26:27-35.
17. Guler M.L., Gorham J.D., Hsieh C.S., Mackey A.J., Steen R.G., Dietrich W.F., Murphy K.M. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 1996, 271:984-987.
18. Hofstetter H.H., Luhder F., Toyka K.V., Gold R. IL-17 production by thymocytes upon CD3 stimulation and costimulation with microbial factors. Cytokine 2006, 34:184-197.
19. Hospenthal D.R., Kwon-Chung K.J., Bennett J.E. Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med. Mycol. 1998, 36:165-168.
20. Huang W., Na L., Fidel P.L., Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 2004, 190:624-631.
21. Latge J.P. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 1999, 12:310-350.
22. Kleinschek M.A., Muller U., Brodie S.J., Stenzel W., Kohler G., Blumenschein W.M., Straubinger R.K., McClanahan T., Kastelein R.A., Alber G. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J. Immunol. 2006, 176:1098-1106.
23. Matsuzaki G., Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol. Immunol. 2007, 51:1139-1147.
24. Mebius R.E., Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 2005, 5:606-616.
25. + T helper type 1 cell responses to Candida albicans. J. Exp. Med. 1998, 187:307-317.
26. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., Hill A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000, 164:6166-6173.
27. Mirkov I., Zolotarevski L., Glamoclija J., Kataranovski D., Kataranovski M. Experimental disseminated aspergillosis in mice: histopathological study. J. Med. Mycol. 2008, 18:75-82.
28. Mirkov I., Stojanovic I., Stosic-Grujicic S., Glamoclija J., Zolotarevski L., Kataranovski D., Kataranovski M. Splenic and lung response to nonlethal systemic Aspergillus infection in C57BL/6 mice. Med. Mycol 2010, 10.3109/13693780903496591.
29. Mossman T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7:145-173.
30. Mullins J., Hutcheson P.S., Slavin R.G. Aspergillus fumigatus spore concentration in outside air: Cardiff and St Luis compared. Clin. Allergy 1984, 14:351-354.
31. Nagai H., Guo J., Choi H., Kurup V. Interferon-γ and tumor necrosis factor-α protect mice from invasive aspergillosis. J. Infect. Dis. 1995, 172:1554-1560.
32. Nolard N. Links between risks of aspergillosis and environmental contamination. Review of the literature. Pathol. Biol. 1994, 42:706-710.
33. Polak A. Experimental models in antifungal chemotherapy. Mycoses 1998, 41:1-30.
34. Rex J.H., Bennett J.E., Gallin J.I., Malech H.L., DeCarlo E.S., Malnick D.A. In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J. Infect. Dis. 1991, 163:849-852.
35. Roilides E., Uhlig K., Venzon D., Pizzo P.A., Walsh T.J. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and γ-interferon. Infect. Immun. 1993, 61:1185-1193.
36. Schmidt A. Animal models of aspergillosis - also useful for vaccination strategies?. Mycoses 2002, 45:38-40.
37. Sheppard D.C., Marr K.A., Fredricks D.N., Chiang L.Y., Doedt T., Filler S.G. Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis. Clin. Microbiol. Infect. 2006, 12:376-380.
38. Stephens-Romero S.D., Mednick A.J., Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect. Immun. 2005, 73:114-125.
39. Svirshchevskaya E.V., Shevchenko M.A., Hue D., Femenia F., Latge J.P., Boireau P., Berkova N.P. Susceptibility of mice to invasive aspergillosis correlates with delayed cell influx into the lungs. Int. J. Immunogen. 2009, 36:289-299.
40. Takemoto K., Yamamoto Y., Ueda Y., Sumita Y., Yoshida K., Niki Y. Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis. J. Antimicrob. Chemother. 2004, 53:311-317.
41. Taborda C.P., Juliano M.A., Puccia R., Franco M., Travassos L.R. Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Infect. Immun. 1998, 66:786-793.
42. Tam M., Snipes G.J., Stevenson M.M. Characterization of chronic bronchopulmonary Pseudomonas aeruginosa infection in resistant and susceptible inbred mouse strains. Am. J. Respir. Cell. Mol. Biol. 1999, 20:710-719.
43. Thach D.C., Kimura T., Griffin D.E. Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus. J. Virol. 2000, 74:6156-6161.
44. Wakeham J., Wang J., Xing Z. Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL/6 and BALB/c mice. Infect. Immun. 2000, 68:6946-6953.
45. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007, 25:821-852.
46. Zaas A.K., Liao G., Chien J.W., Weinberg C., Shore D., Giles S.S., Marr K.A., Usuka J., Burch L.H., Perera L., Perfect J.R., Peltz G., Schwartz D.A. Plasminogen allels influence susceptibility to invasive aspergillosis. PLoS Genet. 2008, 4:e1000101. 10.1371/journal.pgen.1000101.
47. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., Belladonna M.L., Vacca C., Conte C., Mosci P., Bistoni F., Puccetti P., Kastelein R.A., Kopf M., Romani L. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 2007, 37:2695-2706.
48. Zelante T., Bozza S., De Luca A., D'Angelo C., Bonifazi P., Moretti S., Giovannini G., Bistoni F., Romani L. Th17 cells in the setting of Aspergillus infection and pathology. Med. Mycol. 2009, 47:S162-S169.